Five common types of medication that make it hard to cope in the heat
As temperatures rise, so does the risk of heat-related illness, especially for people taking certain prescription drugs.
The body uses several mechanisms to regulate temperature: sweating, blood flow to the skin and fluid balance. But some commonly prescribed drugs interfere with these processes, making it harder to stay cool.
Here are a few you should know about this summer:
Two specific types of antidepressants – selective serotonin reuptake inhibitors (SSRIs) and tricyclics (TCAs) – may make summer harder to cope with. They could even cause heat intolerance due to how they affect the body's ability to sweat.
Both these antidepressants are believed to partly work by affecting neurotransmitter levels in the brain – primarily serotonin and noradrenaline. However, they may also affect other neurotransmitters.
For instance, TCAs can block acetylcholine, a neurotransmitter important for sweating. This may cause some patients to sweat less. On a hot day, this could make it hard to cool down.
However, TCAs also increase noradrenaline levels, a neurotransmitter that stimulates sweat glands. This can increase sweating. In fact, both SSRIs and TCAs can increase sweating in users. Data shows up to 14% of antidepressant users experience this side-effect.
SSRIs may also interfere with the hypothalamus – the brain region that controls body temperature and tells the sweat glands to start producing sweat. But this signal may be affected by the increased serotonin levels.
Since sweating is a key cooling mechanism, any disruptions to this process can lead to heat-related illness. Excess sweating may also cause dehydration if fluids aren't replaced.
Antipsychotics are used to treat psychosis, which can occur in schizophrenia and bipolar disorder. They do this by blocking the neurotransmitter dopamine – which in turn affects levels of the neurotransmitter serotonin. This can disrupt the hypothalamus's ability to sense and respond to body temperature changes.
As a result, someone taking an antipsychotic might not feel overheated or thirsty when it's hot out. This can cause low blood pressure and reduced heart function. The body then tries to compensate by narrowing the blood vessels and holding in heat. This, in turn, reduces sweating and makes it harder to cool down properly.
Additionally, antipsychotics have anticholinergic properties. This means they block the action of acetylcholine, making it harder to sweat.
Beta-blockers are used to manage heart failure and arrhythmias. They do this by lowering the heart rate and reducing how forcefully the heart pumps. But this can limit blood flow to the skin, making it harder for the body to release heat on hot days.
Diuretics are also commonly used in the treatment of high blood pressure or heart failure. But as these drugs increase urine output, this may lead to dehydration and electrolyte imbalances during hot weather. With less fluid available, the body may struggle to sweat properly. If you become severely dehydrated, you might actually stop feeling thirsty. Blood pressure can also drop, which may cause dizziness or fainting – especially when standing up.
Ramipril and losartan, also used to manage blood pressure, can increase the risk of dehydration as well. These drugs block a system in the body that helps control blood pressure, fluid balance and thirst. This may reduce your natural urge to drink, increasing dehydration risk when it's hot.
Stimulants – such as the amphetamines used for ADHD – affect many brain chemicals, including dopamine and noradrenaline. This can increase body temperature, boost metabolism and change how the body sweats – all of which can make it harder to cool down, especially when exercising or in hot weather. This can also potentially lead to dehydration, overheating or even heatstroke. Stimulants may also reduce the feeling of tiredness, which can cause people to overexert themselves without realising the danger.
However, some recent research shows people with ADHD who take stimulants may actually have a lower chance of heat-related illnesses – but larger trials are needed to investigate further. The researchers hypothesise that this protective effect may be due to factors such as lower body weight and users staying hydrated.
Warm temperatures cause the body's blood vessels to dilate (widen) in order to help us cool off. But this action means insulin is absorbed into the bloodstream faster, as there's enhanced blood flow to the area where insulin is injected, making blood sugar drop more quickly. This can lead to hypoglycemia (low blood glucose level), which may lead to dizziness, shaking, sweating, irritability and even potentially loss of consciousness or seizures.
Faster insulin absorption can also make it harder for people with diabetes to notice signs of low blood sugar in the heat, since common symptoms may be mistaken for being hot.
Heat can also degrade insulin, reducing its effectiveness and making it unsafe. This is why insulin should be stored in the fridge until use – especially in summer. Damaged insulin will change appearance – turning cloudy or changing colour.
Older adults, people with chronic conditions (especially those with heart or lung disease) and those taking multiple prescription drugs are especially vulnerable to heat-related illnesses.
Fortunately, there are steps you can take to stay safe during summer if you're taking one of these common prescription drugs.
First, check labels for storage instructions. Avoid leaving medications in hot places, such as in cars or on windowsills. Insulin isn't the only drug affected by heat – inhalers and EpiPens can also malfunction or become less effective.
Second, stay hydrated when it's hot – unless your doctor has advised otherwise. Dehydration can actually worsen the effects of many medicines. For example, anti-inflammatory painkillers (such as ibuprofen) are more likely to cause kidney problems and bipolar medicines (including lithium) can become toxic if you're dehydrated.
Avoid peak heat hours and stay in cool environments when possible. Watch for warning signs of heat-related illness – such as dizziness, confusion, nausea or excessive sweating.
Last, don't stop taking your prescription medication without medical advice. If it's affecting your ability to cope with the heat, speak with your doctor or pharmacist.
Dipa Kamdar is a Senior Lecturer in Pharmacy Practice at Kingston University.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
West Nile Virus found in mosquitoes in Lubbock County, warns city. Here's what to know
The City of Lubbock is warning Lubbock County residents that West Nile Virus has been detected in mosquitoes in the county. According to the city, the Biological Threat Research Lab at Texas Tech University has notified the Lubbock Health Department that mosquitoes carrying West Nile Virus are active in Lubbock County. Others are reading: What's coming in Lubbock County's proposed budget? Here's what's being discussed In response, the vector control teams will increase spraying within the community, with the city strongly urging the public to take precautions to reduce mosquito bites and help prevent the spread of the virus. The city is also asking residents to help prevent the spread of the virus by reporting biting adult mosquitoes or reporting a suspected mosquito breeding site. According to the health department, West Nile is a disease of birds that humans are exposed to after a mosquito has fed on an infected bird. Humans can only contract it from mosquitoes and cannot pass it to other humans. For more information about West Nile Virus, visit the CDC website: According to the health department, here are the common symptoms: Headache. Fever. Muscle and joint aches. Nausea. Fatigue. Symptoms involving the central nervous system can also develop, which include neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, and paralysis. According to the health department, most infected people show no symptoms, with most recovering on their own. Currently, there are no medications or vaccines to prevent or treat infection. People over 50 years old and those with other health issues are at a higher risk of becoming seriously ill. If people have symptoms and suspect West Nile Virus infection, they should contact their healthcare provider. Individuals can take the following steps to prevent infection this holiday week and throughout summer: Wearing an EPA-registered insect repellant Covering up with long-sleeved shirts and long pants Keeping mosquitoes out of living areas by using air conditioning or intact window screens Limiting outdoor activities during peak mosquito times Dumping standing water around your home As of June 18, there have been no reported human West Nile infection cases or deaths in Lubbock in 2025. Mateo Rosiles is the Government & Public Policy reporter for the Lubbock Avalanche-Journal. Got a news tip for him? Email him: mrosiles@ This article originally appeared on Lubbock Avalanche-Journal: West Nile Virus found in mosquitoes around Lubbock, city urges caution
Yahoo
40 minutes ago
- Yahoo
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 10 best healthcare penny stocks to buy according to analysts. The company's stock surged 12.1% on June 23 after it announced positive six-month follow-up results from an investigator-sponsored, first-in-human study of its type 1 diabetes treatment. A laboratory cultivating cells for the development of gene and cell therapies. The therapy in focus is UP421, which consists of cadaver-sourced pancreatic islet cells that have been genetically modified using Sana's hypoimmune (HIP) technology to evade immune detection. A significant finding is that the transplanted cells were safe, well-tolerated, survived, and continued to produce insulin in the patient without the need for immunosuppressive medicines. The study identified no safety issues, and the HIP-modified islet cells successfully evaded immune responses (both allogeneic and autoimmune). Per-Ola Carlsson, MD, Study Principal Investigator, Senior Physician, and Professor at the Clinic for Uppsala University Hospital, stated that the consistent results at four-week, 12-week, and now six-month follow-ups continue to suggest that a functional cure for type 1 diabetes without immunosuppression is possible. Sana Biotechnology, Inc. (NASDAQ:SANA) is a biotechnology company. It develops engineered cell therapies to treat serious diseases, aiming to repair or replace damaged cells. Its platforms include hypoimmune cells, gene delivery, and in vivo cell engineering. Sana's pipeline targets conditions like cancer, type 1 diabetes, and genetic disorders. While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None.


Fox News
44 minutes ago
- Fox News
Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells
A potentially deadly fungus known as "pharaoh's curse fungus" could offer an unexpected path to fighting cancer, recent research shows. Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties. "Fungi gave us penicillin," said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. "These results show that many more medicines derived from natural products remain to be found." The findings were published in the journal Nature Chemical Biology. Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic. While the fungus doesn't endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications. Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated. After archaeologists opened King Tut's tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a "curse" upon those who dared interfere with the pharaoh's rest, according to the UPenn press release. Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team. In the 1970s, it happened again, the university stated. A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb. Now, the same fungus linked to King Tut's tomb could have the capability to fight leukemia in a new form of cancer therapy. "There are a variety of compounds able to be produced by fungus," Gao told Fox News Digital. These compounds can be toxic to different cells, she noted, depending on the "biological management we are able to mitigate." The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or "RiPPs" — within Aspergillus flavus, which was previously shown to be a good source. When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth. "Cancer cells divide uncontrollably," Gao said in the release. "These compounds block the formation of microtubules, which are essential for cell division." When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found. Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin). Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages. "It's still very far away from being applicable to use in humans with leukemia," Troso-Sandoval, who was not involved in the study, told Fox News Digital. Speaking about RiPPs, the doctor told Fox News Digital, "What they're referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus." There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms. "One treatment might not work on [another] type of leukemia," she noted. Further testing is needed to determine which subtypes may contain the active molecule. The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted. This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications. Looking ahead, the researchers plan to test the fungus' potential in animal models and, ultimately, human trials. Gao told Fox News Digital she is "excited about what nature can create and how it can benefit our society." For more Health articles, visit The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science Foundation.